Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV

Science

Volumn 320, Issue 5876, 2008, Pages 649-652

  Wender, Paul A ^a   Kee, Jung Min ^a   Warrington, Jeffrey M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 DEOXYPHORBOL 13 PHENYLACETATE; BIOFUEL; CROTOPHORBOLONE; DITERPENE; PHORBOL DERIVATIVE; PROSTRATIN; 12 DEOXYPHORBOLPHENYLACETATE; 12-DEOXYPHORBOLPHENYLACETATE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PHORBOL; PHORBOL ESTER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS;

AIDS PATIENT; ANTIVIRAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ERADICATION THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS LOAD; ADJUVANT CHEMOTHERAPY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PHYSIOLOGY; SYNTHESIS;

ANTI-HIV AGENTS; CHEMOTHERAPY, ADJUVANT; HIV-1; HUMANS; MODELS, MOLECULAR; PHORBOL ESTERS; PHORBOLS; VIRAL LOAD; VIRUS LATENCY;

EID: 43249122214     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1154690     Document Type: Article

References (47)

1. UNAIDS/WHO, AIDS Epidemic Update: December 2007, available at http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf.
2. T.-W. Chun et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13193 (1997).
3. Q. E. Yang, Med. Sci. Monit. 10, 155 (2004).
4. J. D. Siliciano et al., J. Infect. Dis. 195, 833 (2007).
5. J. Laurence, S. K. Sikder, S. Jhaveri, J. E. Salmon, Biochem. Biophys. Res. Commun. 166, 349 (1990).
6. K. A. Roebuck, D. S. Gu, M. F. Kagnoff, AIDS 10, 819 (1996).
7. S. Bocklandt, P. M. Blumberg, D. H. Hamer, Antiviral Res. 59, 89 (2003).
8. A. Biancotto et al., J. Virol. 78, 10507 (2004).
9. J. Kulkosky et al., Blood 98, 3006 (2001).
10. Y. D. Korin, D. G. Brooks, S. Brown, A. Korotzer, J. A. Zack, J. Virol. 76, 8118 (2002).
11. J. Kulkosky et al., AIDS Res. Hum. Retroviruses 20, 497 (2004).
12. R. J. Gulakowski, J. B. McMahon, R. W. Buckheit Jr., K. R. Gustafson, M. R. Boyd, Antiviral Res. 33, 87 (1997).
13. M. Witvrouw et al., Antiviral Chem. Chemother. 14, 321 (2003).
14. J. Rullas et al., Antiviral Ther. 9, 545 (2004).
15. M. Hezareh et al., Antiviral Chem. Chemother. 15, 207 (2004).
16. S. A. Trushin et al., J. Virol. 79, 9821 (2005).
17. S. A. Williams et al., J. Biol. Chem. 279, 42008 (2004).
18. S. J. Brown et al., paper presented at the 15th International AIDS Conference, Bangkok, Thailand, 11 to 16 June 2004 (abstract no. TuPeB4490), available at http://gateway.nlm.nih.gov/MeetingAbstracts/102282312.html.
19. F. J. Evans, R. G. Schmidt, Acta Pharmacol. Toxicol. (Copenhagen) 45, 181 (1979).
20. A. R. Cashmore et al., Tetrahedron Lett. 17, 1737 (1976).
21. G. A. Miana, M. Bashir, F. J. Evans, Planta Med. 51, 353 (1985).
22. P. A. Cox, Pharm. Biol. 39, 33 (2001).
23. K. R. Gustafson et al., J. Med. Chem. 35, 1978 (1992).
24. H. Johnson, S. A. Banack, P. A. Cox, paper presented at the 48th Annual Meeting of Society for Economic Botany, Chicago, IL, 4 to 7 June 2007, available at www.econbot.org/_organization_/07_annual_meetings/meeting_abstracts/2007. php.
25. J. Hongpaisan, D. L. Alkon, Proc. Natl. Acad. Sci. U.S.A. 104, 19571 (2007), and references therein.
26. H. Black, Scientist 18, 59 (2004).
27. P. A. Wender et al., Curr. Drug Discov. Technol. 1, 1 (2004).
28. Z. Szallasi, L. Krsmanovic, P. M. Blumberg, Cancer Res. 53, 2507 (1993).
29. D. A. Cairnes, S. S. Mirvish, L. Wallcave, D. L. Nagel, J. W. Smith, Cancer Lett. 14, 85 (1981).
30. H. W. Thielmann, E. Hecker, Liebigs Ann. Chem. 728, 158 (1969).
31. P. A. Wender et al., J. Am. Chem. Soc. 111, 8957 (1989).
32. P. A. Wender, F. E. McDonald, J. Am. Chem. Soc. 112, 4956 (1990).
33. P. A. Wender, K. D. Rice, M. E. Schnute, J. Am. Chem. Soc. 119, 7897 (1997).
34. M. Gschwendt, E. Hecker, Tetrahedron Lett. 11, 567 (1970).
35. M. Hirota et al., Cancer Res. 48, 5800 (1988).
36. W. Haas, H. Sterk, M. Mittelbach, J. Nat. Prod. 65, 1434 (2002).
37. D. Fairless, Nature 449, 652 (2007).
38. V. W. Bowry, K. U. Ingold, J. Am. Chem. Soc. 114, 4992 (1992).
39. H. Bartsch, E. Hecker, Z. Naturforsch. Teil B 24, 91 (1969).
40. Materials and methods are detailed in supporting material available on Science Online.
41. P. S. Engel, L. Shen, Can. J. Chem. 52, 4040 (1974).
42. J. P. Freeman, J. Org. Chem. 29, 1379 (1964).
43. For an example of demonstrated technology for large-scale organic photolysis, see (46).
44. J. E. H. Buston, T. D. W. Claridge, M. G. Moloney, J. Chem. Soc. Perkin Trans. 2 1995, 639 (1995).
45. S.-S. Tseng, B. L. Van Duuren, J. J. Solomon, J. Org. Chem. 42, 3645 (1977).
46. B. D. A. Hook et al., J. Org. Chem. 70, 7558 (2005).
47. We thank T. Benvegnu and T. Storz-Eckerlin (Stanford University) for exploratory studies on this project. This work was supported by grants from NIH to P.A.W. (CA31841 and CA31845).